Sysmex Corp - ESG Rating & Company Profile powered by AI
The analysis of Sysmex Corp leverages data from across the web and also from available disclosures by Sysmex Corp. This ESG assessment for Sysmex Corp represents its transparency towards the UN SDGs. This article contains a Q&A table for Sysmex Corp.
Sysmex Corp in the Medical Equipment, Supplies & Distribution industry gained a UN SDG ESG Transparency Score of 7.6; made up of an environmental score of 8.0, social score of 8.0 and governance score of 6.9.
7.6
High ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Bioteque Corp | 8.0 | High |
1 | Amplitude Surgical SA | 8.0 | High |
35 | DENTSPLY SIRONA Inc | 7.7 | High |
35 | Smith & Nephew PLC | 7.7 | High |
37 | Sysmex Corp | 7.6 | High |
37 | ConvaTec Group PLC | 7.6 | High |
37 | Glaukos Corp | 7.6 | High |
... | ... | ... | |
380 | ZoomMed Inc | 0.0 | Low |
380 | iRay Technology Co Ltd | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Sysmex Corp have an accelerator or VC vehicle to help deliver innovation?
Does Sysmex Corp disclose current and historical energy intensity?
Does Sysmex Corp report the average age of the workforce?
Does Sysmex Corp reference operational or capital allocation in relation to climate change?
Does Sysmex Corp disclose its ethnicity pay gap?
Does Sysmex Corp disclose cybersecurity risks?
Does Sysmex Corp offer flexible work?
Does Sysmex Corp have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Sysmex Corp disclose the number of employees in R&D functions?
Does Sysmex Corp conduct supply chain audits?
Does Sysmex Corp disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Sysmex Corp conduct 360 degree staff reviews?
Does Sysmex Corp disclose the individual responsible for D&I?
Does Sysmex Corp disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Sysmex Corp disclose current and / or historical scope 2 emissions?
Does Sysmex Corp disclose water use targets?
Does Sysmex Corp have careers partnerships with academic institutions?
Did Sysmex Corp have a product recall in the last two years?
Does Sysmex Corp disclose incidents of discrimination?
Does Sysmex Corp allow for Work Councils/Collective Agreements to be formed?
Has Sysmex Corp issued a profit warning in the past 24 months?
Does Sysmex Corp disclose parental leave metrics?
Does Sysmex Corp disclose climate scenario or pathway analysis?
Does Sysmex Corp disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Sysmex Corp disclose the pay ratio of women to men?
Does Sysmex Corp support suppliers with sustainability related research and development?
Does Sysmex Corp disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Sysmex Corp reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Sysmex Corp involved in embryonic stem cell research?
Does Sysmex Corp disclose GHG and Air Emissions intensity?
Does Sysmex Corp disclose its waste policy?
Does Sysmex Corp report according to TCFD requirements?
Does Sysmex Corp disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Sysmex Corp disclose energy use targets?
Does Sysmex Corp disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Sysmex Corp have a policy relating to cyber security?
Have a different question?
Potential Risks for Sysmex Corp
These potential risks are based on the size, segment and geographies of the company.
Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. The company offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. It also provides urine formed sediment analysis systems; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS. In addition, the company offers cancer lymph node metastasis testing systems to detect information to help in diagnosing lymph node metastasis; cancer genome profiling systems; and cytogenic testing and lab assay services. It is also involved in the development and sale of software for diagnostic information systems; provision of facility management, office, and welfare services; development, manufacture, and sale of nucleic acid analogs; development, operation, and maintenance of IT solutions, platforms, and applications related to digital medicine; marketing, development, design, manufacture, sale, and after-sales service related to medical robots; and distribution and after sales support of medical devices and reagents for biotechnology, medical technology, and molecular cell analysis. The company serves national and other public hospitals, private hospitals, universities, research institutes, other medical institutions, etc. It also exports its products to approximately 190 countries. Sysmex Corporation has a strategic alliance with QIAGEN N.V. for the development and commercialization of cancer companion diagnostics using Plasma-Safe-SeqS technology. The company was formerly known as TOA Medical Electronics Co., Ltd. and changed its name to Sysmex Corporation in October 1998. Sysmex Corporation was founded in 1968 and is headquartered in Kobe, Japan.